Kumar Budur - 01 May 2023 Form 3 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Christian Ulrich, Attorney-in-Fact
Issuer symbol: HRMY
Transactions as of: 01 May 2023
Net transactions value: $0
Form type: 3
Filing time: 26 Jan 2024, 16:58:43 UTC
Next filing: 26 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	HRMY	Common Stock						1,005	01 May 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	HRMY	Stock Options							01 May 2023	Common Stock	75,000	$49.27	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option vests with respect to 50% of the underlying shares on March 21, 2024, with the remaining shares vesting in twenty-four equal monthly installments beginning on April 21, 2024, subject to the Reporting Person's continued service through each applicable vesting date.